IL6 and chronic obstructive pulmonary disease: In particular, lipid carriers, dendrimers, and biodegradable polymers have been used for the delivery of anti-inflammatory miRNAs and siRNAs aimed at reducing TNF-α, IL-6, and other pro-inflammatory mediators involved in COPD.